Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
The precise mechanism about drug resistance of cancer stem cells (CSCs) has not yet been completely understood. Based on the expression of CD44 and CD133, two well-recognized cell surface markers for CSC identification, we tried to separate HCT8 colorectal cancer cells into different subpopulations...
Saved in:
Main Authors: | Shinji Goto, Tsuyoshi Kawabata, Tao-Sheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/8868849 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells
by: Ade Kallas-Kivi, et al.
Published: (2016-01-01) -
Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
by: Luyao Wu, et al.
Published: (2025-02-01) -
Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
by: Jian‐Hua Wang, et al.
Published: (2019-03-01) -
CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies
by: Tomasz Kloskowski, et al.
Published: (2020-01-01) -
Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases
by: Cornelia Thoeni, et al.
Published: (2019-01-01)